Skip to main content

Table 2 ICSI Procedure: Comparison between the Leukocytospermia (Group I) and Non-leukocytospermia (Group II) groups

From: The influence of leukocytospermia on the outcomes of assisted reproductive technology

 

ICSI procedure

 

Group I Leukocytospermia

Group II Non-leukocytospermia

P value

Cycles

25

25

 

Leukocytes in semen (x106) (mean ± SD)

2.4 ± 1.7 (1–8)

<1

 

Female age (years)

34.4 ± 3.8

34.5 ± 3.6

>0.99

Male age (years)

37.27 ± 5.0

36.7 ± 5.0

0.71

Aetiology (%)

  

0.41

Male

56% (14/25)

40% (10/25)

 

Idiopathic

16% (4/25)

16% (4/25)

 

Tuboperitoneal

12% (3/25)

8% (2/25)

 

Endometriosis

8% (2/25)

28% (7/25)

 

Tuboperitoneal + endometriosis

4% (1/25)

8% (2/25)

 

Male + tuboperitoneal

4% (1/25)

----

 

Semen parametersa (mean ± SD)

   

Total sperm count (x106/mL)

43.2 ± 44.5

69.7 ± 51.5

0.06

Motility (% spermatozoa)

35.8 ± 17.8

50.7 ± 17.9

0.005

-rapid + slow progression

11.9 ± 12.3

11.2 ± 10.3

0.72

-non-progressive

50.4 ± 23.6

35.9 ± 13.6

0.0069

-immotile Morphology

  

0.06

-normal forms (%)

10.1 ± 0.8

17.9 ± 20.3

0.68

Vitality (%)

45.1 ± 17.5

48.8 ± 20.9

0.72

Metaphase II oocytes (n)

8.5 ± 4.2

7.3 ± 4.2

0.32

Fertilisation rate (%)

57.9 ± 30.2

61.9 ± 27.7

0.74

Embryos transfer (n)

2.2 ± 0.9

2.1 ± 1.0

0.60

Implantation rate (%)

12.3% (7/54)

13.5% (7/52)

0.93

Pregnancy/cycle (%)

24% (6/25)

24% (6/25)

1

Miscarriage (%)

0

0

 

Ongoing pregnancy/cycle (%)

24% (6/25)

24% (6/25)

1

Live birth/cycle (%)

24% (6/25)

24% (6/25)

1

  1. a Semen quality parameters according to the World Health Organization [1].